Multiple Myeloma Hub 07.09.20 How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease Read
Genetic Engineering and Biotechnology News 07.01.20 Leaps in Innovation in Cancer Immunology: An Expert Panel Discussion Read
Cancer Therapy Advisor 06.08.20 Early-Memory T-Cell Population May Predict CAR-T Efficacy in Several Hematological Malignancies Read
The ASCO Post 05.10.20 Parker Institute for Cancer Immunotherapy Appoints Frederic Pla, PhD, as Chief Operating Officer Read
ASH Clinical News 05.01.20 CPRIT Awards $19.6 Million to MD Anderson, Sidney Kimmel Establishes Philadelphia T-cell Lymphoma/Leukemia Initiative, and more Read
Endpoints News 04.09.20 Frederic Pla enlisted as COO at the Parker Institute; Former Alkermes exec named CMO at Seres Therapeutics Read
The ASCO Post 03.25.20 The Parker Institute for Cancer Immunotherapy Awards $2.75 Million to Support Six Early-Career Researchers Read
Medical Xpress 03.10.20 CRISPR-edited immune cells can survive and thrive after infusion into cancer patients Read